PUBLIC COMPANY
saveSanaria Inc
updated 4mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
- phase2PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali
- phase2Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria
- phase1Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
- phase1Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults
- phase2Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults
- phase1A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI
- phase2PfSPZ Vaccine Trial in Malian Children
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that